We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLSN -- Ignore unavailable to you. Want to Upgrade?

To: John D. White who wrote (4)1/31/2013 10:03:20 AM
From: Glenn Petersen  Respond to of 5
InPlay 7:38AM Celsion trading down 84% on disappointing Phase III data on ThermoDox in Primary Liver Cancer; Study did not provide sufficient evidence of clinical effectiveness ( CLSN) 8.02 :
  • See 6:06 comment for detail.
  • Stock is trading at 1.25 in pre-mkt.
  • Company to host conference call at 8:00 AM EST today